JNJ

Arrowhead Pharmaceuticals Closes Agreements with Janssen Worth Up To $3.7 Billion
Arrowhead Pharmaceuticals
Janssen
JNJ
Flag link:
Genmab and Johnson & Johnson’s Darzalex Dazzles in Multiple Myeloma Trial
Genmab and Johnson & Johnson’s Darzalex Dazzles in Multiple Myeloma Trial
BioSpace
JNJ
Janssen
Genmab
Darzalex
clinical trials
Multiple Myeloma
Flag link:
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients
CP Wire
Janssen
JNJ
Symtuza
HIV
Flag link:
Johnson & Johnson to open JLabs virtual networking pod in Philadelphia
Johnson & Johnson to open JLabs virtual networking pod in Philadelphia
Fierce Biotech
JNJ
JLabs
JPod
innovation
Flag link:
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients
Janssen
JNJ
Symtuza
HIV
Flag link:
Zytiga generics looming as US court nixes J&J patent
Zytiga generics looming as US court nixes J&J patent
Pharmaforum
JNJ
Zytiga
generics
prostate cancer
Flag link:
J&J steps up vaccines R&D—and preps for launches—with €72M plant
J&J steps up vaccines R&D—and preps for launches—with €72M plant
Fierce Pharma
JNJ
vaccines
drug manufacturing
Flag link:
Bayer plans filings for prostate cancer drug darolutamide
Bayer plans filings for prostate cancer drug darolutamide
Pharmaforum
Bayer
darolutamide
prostate cancer
Pfizer
JNJ
Flag link:
Stelara Shines in Three Year Crohn's Disease Study
Stelara Shines in Three Year Crohn's Disease Study
CP Wire
Janssen
JNJ
Stelara
Crohn's Disease
clinical trials
Flag link:
Stelara Shines in Three Year Crohn's Disease Study
Jannsen
JNJ
Stelara
Crohn's Disease
Flag link:
J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
CNBC
JNJ
M&A
Japan
Flag link:
J&J touts latest immune response data for 'mosaic' HIV vaccine program
J&J touts latest immune response data for 'mosaic' HIV vaccine program
Fierce Pharma
JNJ
vaccines
HUV
Africa
Flag link:
Bay Area's Biotech Talent Crisis Puts Job Seekers in the Driver's Seat
Bay Area's Biotech Talent Crisis Puts Job Seekers in the Driver's Seat
BioSpace
JNJ
San Francisco
Bay Area
JLabs
biotech
Flag link:
[video+transcript] What's Behind Johnson & Johnson's Q3 Earnings Success
[video+transcript] What's Behind Johnson & Johnson's Q3 Earnings Success
Motley Fool
JNJ
earnings
Flag link:
J&J takes $630M hit on RSV drug bought with Alios
J&J takes $630M hit on RSV drug bought with Alios
Fierce Biotech
JNJ
RSV
Alios BioPharma
AL-8176
lumicitabine
Flag link:
2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report
2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report
Motley Fool
JNJ
earnings
Pfizer
Merck
Flag link:
J&J stalls development of antiviral from Alios deal
J&J stalls development of antiviral from Alios deal
BioCentury
JNJ
antivirals
Alios BioPharma
AL-8176
lumicitabine
Flag link:
Prescription drugs, lower taxes, power J&J 3Q beat
Prescription drugs, lower taxes, power J&J 3Q beat
Yahoo/AP
JNJ
earnings
Flag link:
J&J posts softer Q3 device sales
J&J posts softer Q3 device sales
MedTech Dive
JNJ
earnings
devices
Flag link:
UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans
UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans
Fierce Pharma
CMS
UnitedHealthcare
Medicare
JNJ
Remicade
biosimilars
Pfizer
Merck
Flag link:

Pages